ZBTB10 as a potential prognosis biomarker and correlates with the tumor immune microenvironment in stomach adenocarcinoma
Upregulated ZBTB10 is significantly correlated with poor survival outcomes and immune infiltration in STAD, revealing that ZBTB10 may serve as a promising prognostic biomarker and a potential target for immunotherapy in STAD.
Authors
- Fuhua Han
- Yingdi Jiang
- Jiang Lin (ORCID: https://orcid.org/0000-0002-4704-9157)
- Ke Wang (ORCID: https://orcid.org/0000-0003-1487-190X)
- Lu Dai (ORCID: https://orcid.org/0000-0002-6818-8535)
- Yan-Jie Zhou (ORCID: https://orcid.org/0000-0001-7191-4449)
- Shali Qiu
Institutions
- Xuzhou Medical College (CN)
- Jiangyin People's Hospital (CN)
- Suzhou Guangji Hospital (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-06-06
- DOI
- https://doi.org/10.1186/s12876-025-04047-y
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Xuzhou Medical University